MCE Conferences Pain Management and Cardiology for Primary Care October 2–4, 2026

Pain Management, Hypertension, Atrial Fibrillation, Heart Failure, Chronic Pain, Anticoagulation & Cardiovascular Updates | 12 CME Credits

The MCE Conferences Pain Management and Cardiology for Primary Care 2026 is a three-day continuing medical education program designed for physicians and healthcare professionals seeking practical, evidence-based updates in cardiovascular medicine and pain management.

Held October 2–4, 2026, at the Fairmont Sonoma Mission Inn & Spa in Sonoma/Napa Wine Country, California, the original program combines expert-led presentations, clinical cases, and interactive discussions.

The curriculum addresses chronic pain, nonopioid treatments, opioid prescribing, geriatric pain management, interventional spine procedures, end-of-life symptom control, hypertension, atrial fibrillation, anticoagulation, dyslipidemia, heart failure, and coronary microvascular disease.

The course emphasizes applying contemporary clinical guidelines, improving medication safety, selecting effective therapies, and developing individualized treatment strategies in primary care.

Course Details

• Organizer: MCE Conferences
• Dates: October 2–4, 2026
• Duration: Three Days
• Venue: Fairmont Sonoma Mission Inn & Spa, California, USA
• Original Format: Live CME Conference
• Scientific Lectures: 12
• Original CME: Up to 12 AMA PRA Category 1 Credits
• ABIM MOC: Up to 12 Points
• AAFP Prescribed Credits: Up to 12
• MATE Act Educational Content: 1.5 Hours
• Primary Specialties: Pain Medicine and Cardiology
• Language: English

Complete Scientific Program

Day 1 – Friday, October 2, 2026

Chronic Pain Management and Hypertension

1. Non-Opioid Pharmacologic Management of Chronic Pain — 7:30–8:30 AM
   Nonopioid analgesics, neuropathic pain, fibromyalgia, back pain, and evidence-based medication algorithms.
2. Opioids for Chronic and Cancer Pain: Rationale Prescribing — 8:35–9:35 AM
   Opioid selection, rotation, titration, side effects, monitoring, and differences between cancer and noncancer pain.
3. Approach to the Treatment of Essential Hypertension — 9:45–10:45 AM
   Hypertension pathophysiology, treatment selection, and the renin–angiotensin–aldosterone system.
4. Resistant Hypertension — 10:50–11:50 AM
   Secondary hypertension, diagnostic evaluation, and treatment-resistant blood pressure.

Day 2 – Saturday, October 3, 2026

Cardiovascular Pharmacology and Advanced Pain Management

5. Atrial Fibrillation and the New Anticoagulants — 7:30–8:30 AM
   Stroke prevention, anticoagulation indications, NOACs/DOACs, bleeding risk, and atrial fibrillation management.
6. Novel-Lipid Lowering Agents Beyond Statin — 8:35–9:35 AM
   PCSK9 inhibitors, newer lipid-lowering medications, cardiovascular risk assessment, and combination therapy.
7. Managing Pain in Geriatric Patients — 9:45–10:45 AM
   Age-related medication considerations, pain assessment, pharmacological risks, and prevention of iatrogenic complications.
8. Interventional Procedures for Spine Pain — 10:50–11:50 AM
   Epidural steroid injections, facet and sacroiliac injections, radiofrequency lesioning, and spinal cord stimulation.

Day 3 – Sunday, October 4, 2026

Palliative Care, Complex Pain and Heart Disease

9. Managing Pain and Symptoms at the End-of-Life — 7:30–8:30 AM
   Palliative analgesia, dyspnea, delirium, terminal secretions, and family-centered end-of-life care.
10. Challenging Pain Scenarios: An Interactive Case-Based Discussion — 8:35–9:35 AM
    Complex pain presentations, clinical reasoning, individualized treatment, and multidisciplinary management.
11. Approach to the Management of Heart Failure — 9:45–10:45 AM
    Guideline-directed medical therapy, RAS blockers, beta blockers, BNP, and treatment optimization.
12. Microvascular Coronary Artery Disease — 10:50–11:50 AM
    Coronary microvascular dysfunction, spontaneous coronary artery dissection (SCAD), diagnosis, and treatment.

Learning Objectives

Upon completion of the original educational activity, participants should be better able to:

• Apply evidence-based nonopioid treatment strategies for chronic and neuropathic pain.
• Develop safe opioid prescribing and monitoring plans for chronic and cancer pain.
• Diagnose and manage essential, resistant, and secondary hypertension.
• Evaluate anticoagulation options and bleeding risks in atrial fibrillation.
• Incorporate PCSK9 inhibitors and other lipid-lowering therapies into cardiovascular prevention.
• Manage pain in older adults while minimizing medication-related complications.
• Assess appropriate indications for interventional spine procedures.
• Improve end-of-life symptom management.
• Apply guideline-directed treatment for heart failure.
• Recognize and manage microvascular coronary disease and SCAD.

Target Audience

• Internal Medicine Physicians
• Family Medicine Physicians
• Primary Care Physicians
• Pain Medicine Specialists
• Cardiologists
• Geriatricians
• Palliative Care Physicians
• Physical Medicine and Rehabilitation Specialists
• Interventional Spine Specialists
• Clinical Cardiac Electrophysiologists
• Nurse Practitioners
• Physician Assistants
• Other Healthcare Professionals

Continuing Medical Education

The original MCE Conferences program was designated for a maximum of 12 AMA PRA Category 1 Credits, 12 ABIM MOC Points, and 12 AAFP Prescribed Credits, subject to eligible participation.

The conference also included 1.5 hours of educational content intended to address MATE Act requirements.

Important: Independently distributed recordings and educational files do not automatically include CME credits, MOC points, official certificates, conference registration, or publisher platform access. Exact video and PDF contents must be verified separately.

Official Program

MCE Pain Management and Cardiology for Primary Care 2026

Short Description

MCE Conferences Pain Management and Cardiology for Primary Care October 2–4, 2026 provides a three-day clinical review of pain medicine, cardiovascular disease, pharmacotherapy, and evidence-based primary care management.

Held at the Fairmont Sonoma Mission Inn & Spa in California, the original conference features 12 scientific lectures covering:

Topics

• Friday, October 2nd

  • Non-Opioid Pharmacologic Management of Chronic Pain (Objectives: 1) Discuss the neurobiology of chronic pain and how this relates to pharmacologic targets 2) Develop a data-driven and practical understanding of dosing, benefits, and side-effects of common non-opioid pharmacologic agents 3) Implement pharmacologic algorithms for treating common pain syndromes, such as acute back pain, fibromyalgia, and neuropathic pain)

  • Opioids for Chronic and Cancer Pain: Rationale Prescribing (Objectives: 1) Highlight the practical aspects of chronic opioid therapy, including opioid selection, rotation, and side-effect management 2) Appreciate the nuances in titration for different pain syndromes 3) Review clinical pearls and strategies for managing chronic opioid therapy, as safely as possible 4) Discuss the use of opioids for cancer pain and how the approach differs from chronic non-cancer pain)

  • Approach to the Treatment of Essential Hypertension (Objectives: 1) Review the underlying pathophysiology of essential hypertension 2) Outline a reasonable treatment approach to essential hypertension based on pathophysiologic principles 3) Appreciate the role of the renin-angiotensin and aldosterone system in control of blood pressure)

  • Resistant Hypertension (Objectives: 1) Review the definition of resistant hypertension 2) Outline the common causes of secondary hypertension 3) Suggest a reasonable evaluation for patients with resistant hypertension)

• Saturday, October 3rd

  • Atrial Fibrillation and the New Anticoagulants (Objectives: 1) Review the indications for anticoagulation for patients with atrial fibrillation 2) Discuss the use of new novel anticoagulants and their bleeding risks 3) Outline a rational approach to the treatment of atrial fibrillation)

  • Novel-Lipid Lowering Agents Beyond Statin (Objectives: 1) Review PCSK9 therapy and newer medications for the treatment of hyperlipidemia 2) Discuss the role of risk in determining hyperlipidemia therapy 3) Outline management algorithms to determine when to use combination therapy for hyperlipidemia)

  • Managing Pain in Geriatric Patients (Objectives: 1) Recognize the nuances in assessing pain in the elderly 2) Review the pharmacologic challenges in managing elderly patients 3) Identify the balance between pain control and iatrogenesis in the elderly population)

  • Interventional Procedures for Spine Pain (Objectives: 1) Recognize the rationale and technical considerations of common minimally invasive interventions for spine-related pain, such as epidural steroid injections, radiofrequency lesioning, facet injections, sacroiliac injections, and spinal cord stimulation 2) Review the data behind the techniques by way of a data-driven literature review 3) Develop a systematic approach to identifying when patients may or may not benefit from interventional spine procedures)

• Sunday, October 4th

  • Managing Pain and Symptoms at the End-of-Life (Objectives: 1) Discuss the optimal measures to control pain at the end-of-life through case-based teaching 2) Manage common end-of-life clinical scenarios, such as dyspnea, delirium, and terminal secretions 3) Discuss how to become more empowered to be able to effectively guide emotional family members through the dying process)

  • Challenging Pain Scenarios: An Interactive Case-Based Discussion (Objectives: 1) Develop a frame to systematically break down and analyze complex pain scenarios 2) Utilize the audience’s collective mind to develop practical strategies to address the various clinical complexities of the cases 3) Become more comfortable and empowered to handle such cases upon returning to the clinical practice)

  • Approach to the Management of Heart Failure (Objectives: 1) Review guideline-directed medical therapy for patients with heart failure 2) Outline a practical approach for the optimal use of RAS blockers and beta blockers in heart failure 3) Discuss the role of BNP as a guide to optimal heart failure therapy)

  • Microvascular Coronary Artery Disease (Objectives: 1) Discuss the prevalence and presentation of microvascular coronary artery disease 2) Review the presentation and management of spontaneous coronary artery dissection 3) Outline a treatment management plan for patients with microvascular disease)